Hematological Findings in COVID-19 and Insights to Stem Cell Therapy: From Bench to Practice
| Author | Sherif Ahmed Mohamed | en |
| Author | Ghada El- Gohary | en |
| Author | Farjah AlGahtani | en |
| Author | Fakher Alayoubi | en |
| Author | Nashwa Abd El-Aziz | en |
| Issued Date | 2021-02-20 | en |
| Abstract | Context: As the COVID-19 was spreading to all countries, its manifestations were identifying gradually, which were related to several organs. Evidence Acquisition: COVID-19 is associated with distinct hematological changes, increased serum inflammatory markers, and coagulopathy. Most of these changes are related to the patients’ prognosis and mortality, particularly in those with severe disease. Results: Firstly, we discussed the associations between COVID-19 clinical features and complications, and secondly, its hematological findings and coagulopathy are investigated. Conclusions: Such associations not only may shed light on our prognostic view of patients with COVID-19 but also will entail significant therapeutic implications. One of its key implications is to utilize the mesenchymal stem cells (MSCs) to treat patients with COVID-19. Herein, this kind of novel therapy will be discussed, as well. | en |
| DOI | https://doi.org/10.5812/jssc.107133 | en |
| URI | https://brieflands.com/journals/jssc/articles/107133 | en |
| Keyword | COVID-19 | en |
| Keyword | Hematological | en |
| Keyword | Immunology | en |
| Keyword | Lymphocytes Prognosis | en |
| Keyword | Mesenchymal Stem Cells | en |
| Publisher | Brieflands | en |
| Title | Hematological Findings in COVID-19 and Insights to Stem Cell Therapy: From Bench to Practice | en |
| Type | Review Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- jssc-7-3-107133.pdf
- Size:
- 130.61 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF